Birgit H. Amann, MD


Final Thoughts on Management of ADHD

ADHD experts share their final thoughts on the treatment and management of ADHD.

Peter Salgo, MD, Columbia University Irving Medical Center


Final Thoughts: Awareness and Communication in Diabetes

Thought leaders in diabetes provide closing remarks about the importance of continuous awareness of glycemic control in patients as well as the need for effective communication between patients and providers. 

Michael R. DeBaun, MD, MPH, Vanderbilt-Meharry Center of Excellence in Sickle Cell Disease


Unmet Needs in Sickle Cell Disease Management

Strategies to avoid complications of sickle cell disease and ensure non-dependency on opioids when treating patients for pain as a result of the disease.

William F. Peacock, MD


Future Directions in the Treatment of Opioid-Induced Constipation

A panel of experts discuss their key takeaways and the future of treating opioid-induced constipation.

Vibeke Strand, MD, MACR, FACP


Improving Management of RA

Vibeke Strand, MD, MACR, FACP, shares the advantages and limitations of the AIMS and comparative cohort studies in the treatment of RA.

Neal Bhatia, MD


Plaque Psoriasis: Future Therapeutic Pipeline

Brad Glick, DO, AOCD, George Han, MD, PhD, and Neal Bhatia, MD, look to the future at what is upcoming in the treatment pipeline for plaque psoriasis treatment.

Carl D. Regillo, MD, FACS


Practical Takeaways and Future Directions in DME and AMD

Retina specialists share advice and practice pearls regarding the management of DME and neovascular AMD, including counseling patients about the importance of healthy lifestyles.

Debra Davis, CRNP


Advice for Advanced Practice Providers in Managing Sleep Disorders

Advanced practice practitioners share final pearls with their colleagues for the management of sleep disorders.



Key Takeaways for Lipid Lowering in Hypercholesterolemia and ASCVD

Drs Erin Michos, Pam Taub, Robert Busch, Alison Bailey, and Jorge Plutzky offer key takeaways in the management of hypercholesterolemia and ASCVD.

Nirmish Shah, MD


Practice Pearls for the Management of SCD

A panel of experts in hematology discuss the future directions for sickle cell disease and share practice pearls for disease management.

Jacinda Abdul-Mutakabbir, PharmD


Addressing Vaccine Hesitancy and Uptake for SARS-CoV-2

Wendy Wright, DNP, ANP-BC, FNP-BC, FAANP, FAAN, FNAP, and Madeline King, PharmD, BCIDP, provide insight on vaccine hesitancy among patients and the importance of increasing vaccine uptake to protect against SARS-CoV-2.

Andrew Cutler, MD


Improving Awareness for Depressive Disorders

Andrew J Cutler, MD; Gregory Mattingly, MD; and Sagar V. Parikh, MD, FRCPC, comment on the need to improve awareness around depressive disorders and break the stigma of mental health treatment.

Ehsan Rahimy, MD


Optimizing Anti-VEGF Treatment Outcomes in Neovascular AMD and DME

In this upcoming program, expert retina specialists discuss long-term experience with anti-VEGF therapies for age-related macular degeneration and diabetic macular edema, and share evidence-based strategies to improve treatment outcomes.

Marc Serota, MD


Key Takeaways on the Optimal Management of Atopic Dermatitis

Closing out their discussion on the management of atopic dermatitis, expert panelists share clinical pearls and key takeaways from their discussion.

Ronald van Vollenhoven, PhD


Systemic Lupus Erythematosus Treatment Advances: Anifrolumab

The rationale for using a newer monoclonal antibody therapy, anifrolumab, to manage patients with systemic lupus erythematosus.

Killian Meara


China Hits 1 Billion COVID-19 Vaccines Administered

Africa sees third wave as only 1% of the population is fully vaccinated.

Matthew J. Budoff, MD


Future Directions for the Treatment of ASCVD and Hypercholesterolemia

Drs Paul S. Jellinger, Erin D. Michos, Matthew J. Budoff, Christie Ballantyne, and Yehuda Handelsman share closing thoughts and advice for the management of ASCVD and hypercholesterolemia.

Christie Ballantyne, MD


Future Directions for the Treatment of ASCVD and Hypercholesterolemia

Drs Paul S. Jellinger, Erin D. Michos, Matthew J. Budoff, Christie Ballantyne, and Yehuda Handelsman share closing thoughts and advice for the management of ASCVD and hypercholesterolemia.

Patrick McGann, MD, MS, Cincinnati Children’s Hospital


What’s Next and Final Thoughts in SCD

Experts look into what is next for sickle cell disease and provide key thoughts on the space.

Raj Chovatiya, MD, PhD


Keeping Physicians Up to Date With AD Advances

Experts in dermatology share advice on helping fellow physicians stay apprised of the advances in AD and treat their patients more effectively.

Manesh R. Patel, MD, Duke University


Cardiovascular Disease: Future Perspectives

Marc P. Bonaca, MD, MPH, of the University of Colorado School of Medicine, comments on the potential to personalize treatment with emerging therapies in the pipeline to better manage patients at high risk for cardiovascular disease in the future.

Erin Boh, MD, PhD, FAAD


Future Directions in the Treatment of Plaque Psoriasis

Key opinion leaders conclude their discussion on plaque psoriasis by commenting on the potential for research into the genetic origin of disease, possible biomarkers, and treatment options with greater efficacy.

Scott Kahan, MD, MPH


Shared Decision-Making to Improve Long-Term Outcomes in Diabetes and Obesity

Drs Diana Isaacs and Natalie Bellini highlight the need for engaging patients in shared decision-making and addressing social determinants of health in diabetes and obesity management in adults and pediatric patients.

Matthew Brunner, PA


Practice Pearls for the Management of Atopic Dermatitis

Alexa Hetzel, MA, PA-C; Lakshi Aldredge, MSN, ANP-BC, DCNP, and Matthew Brunner, PA, share practice pearls and clinical management tips for the care of pediatric patients with atopic dermatitis.

© 2023 MJH Life Sciences

All rights reserved.